Literature DB >> 6208563

Serotonergic involvement in phencyclidine-induced behaviors.

T Nabeshima, K Yamaguchi, M Hiramatsu, M Amano, H Furukawa, T Kameyama.   

Abstract

Administration of 5-10 mg/kg of phencyclidine (PCP) caused stereotyped behaviors including sniffing, backpedalling, head weaving and turning in rats. The PCP-induced stereotyped behaviors (backpedalling, head weaving and turning) were attenuated by serotonin (5-HT) depleters [reserpine, p-chlorophenylalanine, p-chloroamphetamine (PCA)] and 5-HT receptor antagonist (cyproheptadine). PCP-induced head weaving and turning were potentiated by 5-HT precursor (tryptophan) and 5-HT releaser (PCA). PCP-induced head weaving were potentiated also by monoamine oxidase inhibitor (pargyline) and 5-HT reuptake inhibitor (imipramine). PCP 5-10 mg/kg significantly increased the content of 5-HT in the thalamus/hypothalamus at 30 and 60 min after the injection, except PCP 5 mg/kg at 60 min. PCP 7.5 and 10 mg/kg increased the rate of increment of 5-HT by pargyline in the thalamus/hypothalamus at 30 and 60 min after the injection, respectively. PCP 10 mg/kg significantly increased the contents of 5-HIAA in the striatum and thalamus/hypothalamus at 30 min, but decreased that of 5-HIAA in all discrete brain areas except the stratium at 60 min after the injection. PCP also significantly prevented the depletion of 5-HT by PCA in all discrete brain areas except the stratium at 60 min after the injection. From these results, PCP-induced stereotyped behaviors are related to an increased serotonergic neuronal activity due to 5-HT releasing action and/or inhibitory action of 5-HT uptake-by this drug.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208563     DOI: 10.1016/s0091-3057(84)80102-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Inhibition of calcium ATPase by phencyclidine in rat brain.

Authors:  M Pande; J A Cameron; P J Vig; S F Ali; D Desaiah
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

2.  Phencyclidine-induced retrograde amnesia in mice.

Authors:  T Nabeshima; T Kozawa; H Furukawa; T Kameyama
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.

Authors:  Y Noda; K Yamada; H Furukawa; T Nabeshima
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

4.  The effects of acute phencyclidine treatment on neuropeptide Y (NPY) neuronal system in the rat arcuate nucleus studied by immunocytochemistry and in situ hybridization.

Authors:  K Fukui; Y Kawashima; H Iizumi; H Utsumi; T Nakajima
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

5.  Drug-induced circling preference in rats. Correlation with monoamine levels.

Authors:  S F Ali; K J Kordsmeier; B Gough
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

6.  Systemic phencyclidine administration is associated with increased dopamine, GABA, and 5-HIAA levels in the dorsolateral striatum of conscious rats: an in vivo microdialysis study.

Authors:  S M Lillrank; W T O'Connor; S S Oja; U Ungerstedt
Journal:  J Neural Transm Gen Sect       Date:  1994
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.